Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections.

ABSTRACT:

SUBMITTER: Tu SS 

PROVIDER: S-EPMC11320327 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature